Identification of fetal unmodified and 5-hydroxymethylated CG sites in maternal cell-free DNA for non-invasive prenatal testing

BACKGROUND: Massively parallel sequencing of maternal cell-free DNA (cfDNA) is widely used to test fetal genetic abnormalities in non-invasive prenatal testing (NIPT). However, sequencing-based approaches are still of high cost. Building upon previous knowledge that placenta, the main source of feta...

Descripción completa

Detalles Bibliográficos
Autores principales: Gordevičius, Juozas, Narmontė, Milda, Gibas, Povilas, Kvederavičiūtė, Kotryna, Tomkutė, Vita, Paluoja, Priit, Krjutškov, Kaarel, Salumets, Andres, Kriukienė, Edita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574562/
https://www.ncbi.nlm.nih.gov/pubmed/33081811
http://dx.doi.org/10.1186/s13148-020-00938-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574562/
https://www.ncbi.nlm.nih.gov/pubmed/33081811
http://dx.doi.org/10.1186/s13148-020-00938-x

Ejemplares similares